一种利用病原体毒性因子引发天生的免疫力的植物机制
Yu Xiao1,2, Guangzheng Sun3,4,5, Qiangsheng Yu1
1Center for Plant Biology, School of Life Sciences, Tsinghua University, Beijing 100084, China.
概括
植物聚氨酸酶抑制蛋白 (PGIP) 可以被设计为结合病原体酶,将毒性因子转化为植物防御信号. 这种相互作用通过改变细胞壁碎片的产生来增强免疫力.
科学领域:
- 植物免疫力
- 分子植物病原体相互作用
- 蛋白质工程
背景情况:
- 聚氨酸酶抑制蛋白 (PGIPs) 是植物免疫受体的关键.
- 它们与病原体聚氨酸酶结合,抑制病毒性,但引发防御作用.
- 精确的PGIP-多聚氨酸酶相互作用机制及其对信号的影响尚未完全理解.
研究的目的:
- 研究Paseolus vulgaris PGIP2 (PvPGIP2) 和Fusarium phyllophilum polygalacturonase (FpPG) 之间的分子相互作用.
- 阐明这种相互作用如何调节酶活性和下游免疫信号.
- 探索PGIP的工程潜力,以提高其特异性和功能.
主要方法:
- 对PvPGIP2-FpPG复合物的联合结晶和结构分析
- 酶定量测量聚甲酶活性和橄甲胺的产生.
- 基于PGIP的结构蛋白质工程.
主要成果:
- 结合PvPGIP2增强了FpPG基质的结合,并抑制了它的酶活性.
- 这种相互作用促进了长链,免疫活性的甲酸的产生.
- 改造后的PGIP显示了与FPPG的结合和相互作用的改善.
- 在相互作用时形成一种具有增强基质结合和改变偏好的新型多聚氨酸酶.
结论:
- 植物PGIP可以将病原体的毒性因素转化为防御信号.
- PvPGIP2- FpPG相互作用提供了一个将酶抑制转化为免疫激活的机制.
- 工程PGIP为开发更广泛的植物疾病耐药性提供了一个有前途的策略.
相关概念视频
Defenses Against Pathogens and Herbivores
23.7K
Plants present a rich source of nutrients for many organisms, making it a target for herbivores and infectious agents. Plants, though lacking a proper immune system, have developed an array of constitutive and inducible defenses to fend off these attacks.
23.7K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Immune Response Against Viral Pathogens
782
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
782
Infection
7.9K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.9K
Antigen Processing Pathways
1.0K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
1.0K
Receptor-mediated Endocytosis
104.5K
Overview
104.5K


